Faculty Information - SEKIGUCHI Haruki

Books

Published papers

Academic conference presentation

Research grants & projects

Committee memberships

Awards & honors

Patents

（Last updated : 2026-09-14 23:21:00）

SEKIGUCHI Haruki
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine

Position Associate Professor

■ Books

Chapter contribution　

EPC culture assay 2012/01

■ Published papers

1.	Original article	Gender-specific impacts of apnea, age, and BMI on parasympathetic nerve dysfunction during sleep in patients with obstructive sleep apnea. 2014/03
2.	Original article	Estimation of parasympathetic nerve function during sleep in patients with obstructive sleep apnea by instantaneous time-frequency analysis. 2014/01
3.	Original article	Oxygen Preconditioning Prevents Contrast-induced Nephropathy(OPtion CIN Study). 2013/04
4.	Original article	CXCR4 Antagonist AMD3100 Promotes Cardiac Functional Recovery After Ischemia-Reperfusion Injury via eNOS-Dependent Mechanism. 2012/11
5.	Original article	Estradiol promotes neural stem cell differentiation into endothelial lineage and angiogenesis in injured peripheral nerve 2012/09
6.	Original article	The efficacy of neutralizing monoclonal antibodies in transplant recipients with mild-to-moderate COVID-19. 2023/04
7.	Original article	Adherence to CPAP in summer to autumn predicts self-reported common cold symptoms in patients with obstructive sleep apnea in winter: A prospective observational study 2023/03
8.	Original article	High-normal diastolic blood pressure as a risk factor for left ventricular diastolic dysfunction in healthy postmenopausal women. 2022/12
9.	Case report	A novel optimized adaptive servo-ventilation setting for a patient with severe heart failure based on the echocardiogram: a case report. 2022/03
10.	Original article	Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome 2021/04
11.	Case report	A case of heterozygous familial hypercholesterolemia requiring strict low-density lipoprotein cholesterol management with proprotein convertase subtilisin/kexin 9 inhibitor after coronary artery bypass grafting 2021/03/18
12.	Original article	Efficacy of oral myofunctional therapy in middle-aged to elderly patients with obstructive sleep apnoea treated with continuous positive airway pressure. 2021/02
13.	Original article	The Effects of Lipid-Lowering Therapy on Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio: An HIJ-PROPER Sub-Analysis. 2020/06
14.	Original article	Impact of age on clinical outcomes of antihypertensive therapy in patients with hypertension and coronary artery disease: A sub-analysis of the Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease. 2020/05
15.	Original article	Quantitative Volumetric Comparison of Direct Oral Anticoagulant and Vitamin K Antagonist Treatment for Pulmonary Thrombus Reduction During the Acute Phase in Symptomatic Patients. 2020/05
16.	Original article	Effect of Aggressive Lipid-Lowering Therapy in Single-Vessel vs. Multivessel Coronary Artery Disease Patients With Acute Coronary Syndrome　- Heart Institute of Japan-Proper Level of Lipid Lowering With Pitavastatin and Ezetimibe in Acute Coronary Syndrome (HIJ-PROPER) Substudy. 2020/01
17.	Original article	Targeting high-sensitivity C-reactive protein levels in acute coronary syndrome patients undergoing contemporary lipid-lowering therapy: a sub-analysis of the HIJ-PROPER trial. 2019/11
18.	Original article	Polyunsaturated Fatty Acid Impact on Clinical Outcomes in Acute Coronary Syndrome Patients With Dyslipidemia: Subanalysis of HIJ-PROPER. 2019/08
19.	Original article	Predictive Value of Baseline High-Sensitivity C-Reactive Protein Level and Renal Function for Patients With Acute Coronary Syndrome Undergoing Aggressive Lipid-Lowering Therapy: A Subanalysis of HIJ-PROPER. 2018/12
20.	Other	Reply to: "Call for an ezetimibe effectivess test". 2018/11
21.	Original article	Baseline serum sitosterol level as predictor of adverse clinical events in acute coronary syndrome patients with dyslipidaemia: A sub-analysis of HIJ-PROPER. 2018/07
22.	Original article	Arousal index as a marker of carotid artery atherosclerosis in patients with obstructive sleep apnea syndrome 2018/05/19
23.	Original article	Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failure. 2017/11
24.	Original article	Cancer antigen-125 plasma level as a biomarker of new-onset atrial fibrillation in postmenopausal women. 2017/09
25.	Original article	Contrast-Induced Nephropathy and Oxygen Pretreatment in Patients With Impaired Renal Function. 2017/08
26.	Original article	Pilot Cohort Study Assessing the Efficacy of Endovascular Revascularization in the Restoration of Peripheral Sensory Disturbance in Patients With Critical Limb Ischemia. 2017/07
27.	Original article	Intimal disruption affects drug-eluting cobalt-chromium stent expansion: A randomized trial comparing scoring and conventional balloon predilation. 2016/10
28.	Original article	Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure. 2016/09
29.	Original article	Efficacy of 24-Hour Blood Pressure Monitoring in Evaluating Response to Percutaneous Transluminal Renal Angioplasty. 2016/08
30.	Original article	Gender differences in predictors of left ventricular myocardial relaxation in non-obese, healthy individuals. 2015/04
31.	Other	Oxygen Pre-Conditioning Prevents Contrast-Induced Nephropathy (OPtion CIN Study) 2013/07
32.	Original article	CXCR4 Antagonist AMD3100 Promotes Cardiac Functional Recovery After Ischemia-Reperfusion Injury via eNOS-Dependent Mechanism 2013/01
33.	Original article	Estradiol triggers sonic-hedgehog-induced angiogenesis during peripheral nerve regeneration by downregulating hedgehog-interacting protein 2012/02
34.	Original article	Improved culture-based isolation of differentiating endothelial progenitor cells from mouse bone marrow mononuclear cells. 2011/12
35.	Original article	CXCR4 Antagonist AMD3100 Accelerates Impaired Wound Healing in Diabetic Mice 2011/11
36.	Original article	CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction 2010
37.	Original article	CXCR4 blockade augments bone-marrow progenitor-cell recruitment to the neovasculature and reduces mortality after myocardial infarction. 2010
38.	Original article	Concurrent Vasculogenesis and Neurogenesis From Adult Neural Stem Cells 2009/10
39.	Review article	The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. 2009/05
40.	Original article	Pulmonary gas transfer related to markers of angiogenesis during the menstrual cycle 2007/08
41.	Original article	Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. 2006/11
Display 5 items
Display all(41)

■ Academic conference presentation

1.	THE EARLY REPOLARIZATION NORMAL VARIANT ELECTROCARDIOGRAM IN HEALTHY JAPANESE （Poster notice，General） 2015/04/29
2.	Marked Improvement of Elderly Symptomatic Postprandial Hypotension by Xanthine Derivatives and Preparations （Poster notice，General） 2015/03/14
3.	The novel pharmacological treatment of symptomatic postprandial hypotension by Xanthine derivatives and Preparations （Poster notice，General） 2014/11/26
4.	Prevention of Contrast-Induced Nephropathy by Oxygen Preconditioning in Patients With Impaired Renal Function （Poster notice，General） 2014/11/17
5.	Gender Differences in Non-BMI Predictors of Left Ventricular Myocardial Relaxation in Non-Obese Individuals （Poster notice，General） 2014/11/17
6.	Marked Improvement of Postprandial Hypotension by Xanthine Derivatives and Preparations （Poster notice，General） 2014/11/17
7.	ERECTILE DYSFUNCTION RISK FACTORS IN PATIENTS WITH SEVERE OBSTRUCTIVE SLEEP APNEA SYNDROME AND IDENTIFYING CPAP RESPONSE PREDICTORS （Poster notice，General） 2014/09/22
8.	Age- and Gender- specific Risk Factors of the Left Ventricular Myocardial Relaxation: Data Obtained thorough Physical Examinations in Healthy Subjects. （Poster notice，General） 2014/05/05
9.	Erectile dysfunction risk factors in patients with severe obstructive sleep apnea syndrome and identifying CPAP response predictors. （Poster notice，General） 2014/05/06
10.	Undesirable effect on lipoprotein profile by cardiovascular surgery （Poster notice，General） 2014/05/05
11.	Age- and Gender- specific Risk Factors of the Left Ventricular Myocardial Relaxation: Data Obtained thorough Physical Examinations in Healthy Subjects （Poster notice，General） 2014/03/21
12.	Relationship between Carbohydrate Antigen-125 and Left Ventricular Wall Stiffing in Women: Data Obtained Through Medical Examinations in Healthy Subjects （Poster notice，General） 2014/03/21
13.	Oxygen preconditioning prevents contrast-induced nephropathy in patients with chronic kidney disease: option CIN-CKD Randomized Trial （Poster notice，General） 2013/09/02
14.	Relationship between Carbohydrate Antigen-125 and left ventricular wall stiffing in women: data obtained through medical examinations in healthy subjects （Poster notice，General） 2013/09/03
15.	Oxygenation Prevents Contrast-induced Nephropathy via Nitric Oxide Induction （Speech，General） 2013/03/24
16.	Oxygenation Prevents Contrast-induced Nephropathy via Nitric Oxide Induction （Speech，Panelist at Symposium/Workshop (Other)） 2013/03/17
17.	Waist Circumference Predicts Abnormal Left Ventricular Relaxation in Men: Data Obtained through Thorough Physical Examinations in Healthy Subjects （Poster notice，General） 2013/03/09
18.	Oxygen Prevents Contrast-induced Nephropathy via Nitric Oxide Induction （Speech，General） 2012/11/07
19.	Oxygen Preconditioning Prevents Contrast-Induced Nephropathy （Poster notice，General） 2012/08/27
20.	Oxygen Preconditioning Prevents Contrast-induced Nephropathy after Coronary Angiography in Patients of Ischemic Heart Disease （Speech，General） 2012/03/16
21.	Oxygen Preconditioning Prevents Contrast-Induced Nephropathy after Coronary Angiography in Patient of Ischemic Heart Disease （Poster notice，General） 2011/11
22.	Estradiol Promotes Neural Stem Cell-based Peripheral Nerve Repair by Enhancing Angiogenesis （Speech，General） 2009/11
23.	Estradiol Improves Neural Functional Recovery After Nerve Injury by Reducing Inhibition of the Hedgehog-signaling pathway （Poster notice，General） 2008/11/11
24.	Neural Stem Cells Contribute to Peripheral Nerve Repair by Coordinated Angiogenesis and Neurogenesis （Speech，General） 2007/11
25.	Waist circumference as a predictor of abnormal left ventricular relaxation in healthy men （Speech，General） 2013/09/22
26.	Risk Factor for Erectile Dysfunction in Patients with SAS and Predictor Identifying Responders to CPAP （Poster notice，General） 2013/06/27
27.	C-reactive Protein Level on Presentation Predicts Inhospital and Long-Term Mortality in Patients with ST elevation Acute Myocardial Infarction in Reperfusion Era - From the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry （Poster notice，General） 2005/06
28.	The impact of sleep disordered breathing (SDB) on the occurrence of heart failure in the patients with hypertrophic cardiomyopathy of benign pathophysiology. （Poster notice，General） 2014/05/05
29.	Assessment of developing heart failure after pacemaker implantation by means of thoracic impedance and cytokines. （Poster notice，General） 2014/05/05
30.	Left Ventricular Relaxation Is Impaired in Subjects With LV Concentric Remodeling （Poster notice，General） 2013/03/10
31.	Cardioprotection by Exogenously Administered Endothelial Progenitor Cells (EPCs) After Ischemia-Reperfusion Injury is eNOS Dependent （Speech，General） 2010/11
32.	CXCR4 Antagonist AMD3100 Preserves Cardiac Function After Myocardial Infarction (MI) via CXCR4 Dependent and Independent Pathways （Speech，General） 2009/11
33.	Single Dose CXCR4 Antagonist Enhances Recovery From Ischemia Reperfusion Injury While Continuous Blockade Abolishes Treatment Effect （Speech，General） 2009/11
34.	CXCR4 Antagonist AMD3100 Preserves Cardiac Function After Ischemia-Reperfusion Injury via eNOS Dependent Mobilization of Bone Marrow Derived Progenitor Cells 2009/11
35.	Stem/Progenitor markers Sca-1 versus C-kit and CD31 Determine Angiogenic Potencial of Mouse Bone Marrow-derived Endothelial Progenitor Cells （Poster notice，General） 2008/11/10
36.	Derivation of Multipotent Stem Cells from Epigenetically Modified Endothelial Progenitor Cells （Speech，General） 2008/11
37.	Estrogen Receptors alfa and beta Mediate Contribution of Bone Marrow-Derived Endothelial Progenitor Cells to Functional Recovery After Myocardial Infarction （Speech，General） 2006/11
38.	Small molecule CXCR4 Antagonist Augments Mobilization and Incorporation of Bone Marrow-Derived Endothelial Progenitor Cells into Sites of Myocardial Neovascularization and Reduces Mortality After Myocardial Infarction （Speech，General） 2006/11
39.	4 Case of Dementia with Lewy Bodies Presenting Nocturnal Hypertension as Found by Presence of Daytime Trembling （Poster notice，General） 2014/10/17
40.	Undesirable Effect on Lipoprotein Profile by Cardiovascular Surgery （Poster notice，General） 2014/09/27
41.	Front Lines of Optimal Management of Atherosclerosis Risks　Lipoprotein(a) is Residual Risk Factor for the Atherosclerotic Cardiovascular Disease in the Well-controlled LDL-C Era （Speech） 2021/03/27
42.	Aortic Valve Calcification and Prognostic Evaluation in Patients with Heterozygous Familial Hypercholesterolemia （Speech，General） 2021/03
43.	PCSK9 Gene Mutations Have a Higher Risk of Cardiovascular Events than LDL Receptor Abnoramalities in Heterozygous Familial Hypercholesterolemia （Speech） 2021/03
44.	Aortic Valve Calcification Predicts Subclinical Coronary Atherosclerosis in Heterozygous Familial Hypercholesterolemia Patients with High LP (a) Levels （Speech，General） 2020/07
45.	High Apolipoprotein-B Level is a Risk Factor of Secondary Cardiovascular Incidence in Patients with Familial Hypercholesterolemia （Speech，General） 2020/07
46.	Activation of Effector Memory and Effector T Cells in Patients with Familial Hypercholesterolemia. （Poster notice，General） 2019/12/11
47.	Aortic Valve Calcification and Subclinical Coronary Atherosclerosis in Japanese Heterozygous Familial Hypercholesterolemia Patients With High Lp(a) Levels （Poster notice，General） 2019/11/17
48.	The Impact of Brain Atrophy in the Patient with Young Patients with Severe Heart Failure （General） 2019/09/02
49.	Differences in the usefulness of aggressive lipid-lowering therapy among single-vessel and multi-vessel coronary artery disease patients: HIJ-PROPER sub-study （Poster notice，General） 2019/08/31
50.	The clinical impact of polyunsaturated fatty acid on clinical outcomes in acute coronary syndrome with dyslipidemia: HIJ-PROPER sub-analysis （Poster notice，General） 2019/08/31
51.	Genetic Diagnosis of Familial Hypercholesterolemia and the Risk of Cardiovascular Events （Poster notice，General） 2019/07/11
52.	Impact on Oral Myofunctional Therapy to Treat The Patients with Moderate to Severe Obstructive Sleep Apnea （Poster notice，General） 2019/06/11
53.	Differences in the Usefulness of Aggressive Lipidlowering Therapy among Single-vessel and Multivessel Coronary Artery Disease Patients: HIJPROPER Sub-study （Speech，General） 2019/03/31
54.	Differences by Age in Efficacy of Guidelinerecommended Medication on Long-term Outcomes in Patients with Acute Heart Failure （Speech，General） 2019/03/30
55.	Genetic Diagnosis of Familial Hypercholesterolemia and the Risk of Cardiovascular Events （Speech，General） 2019/03/29
56.	Aggressive Sodium Restriction in Chronic Heart Failure: 6g vs. 3g a Randomized Study （Poster notice，General） 2019/03/16
57.	Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitor Improve Lipid Profile and Vascular Atherosclerotic Plaque Formation in Japanese High-Risk Familia Hypercholesterolemia （Poster notice，General） 2018/11/12
58.	Target Systolic Blood Pressure For Preventing Cardiovascular Outcomes In Patients With Dyslipidemia Receiving Aggressive Lipid-.lowering Therapy: Findings of the HIJ-PROPER Trial （Poster notice，General） 2018/11/12
59.	Optimized Settings for Adaptive Servo-Ventilation in Patients With Severe Heart Failure Diagnosed Using Echocardiography （Poster notice，General） 2018/11/11
60.	Effect of Combination Theraphy With Ezetimibe And Pitavastatin On Cardiovascular Outcomes in Patients With And Without Hypertension: Findings Of The HIJ-Proper Trial （Poster notice，General） 2018/11/10
61.	Impact of Baseline Low-Density Lipoprotein cholesterole Level and Aggressive Lipid-Lowering Therapy by Ezetimibe on Prognosis of Statin Naive Acute Coronary Syndrome Patients: A Sub-Analysis of the HIJ-PROPER Trial （Poster notice，General） 2018/11/10
62.	Guideline-recommended medication including mineralocorticoid-receptor antagonists is associated with better long-term outcomes in octogenarian patients with acute heart failure （Speech） 2018/10/11
63.	Therapeutic validity and effectiveness of guideline-recommended medical therapy in acute heart failure patients on regular hemodialysis （Speech，General） 2018/10/11
64.	Aortic Vale calcification and coronary atherosclerosis in familial hypercholesterolemia patients （Speech，General） 2018/09/22
65.	The role of ORAIP for the coronary artery plaque instability in Familial Hypercholesterolemia （Speech，General） 2018/09/22
66.	Simple risk score for predicting secondary cardiovascular events in ACS patients undergoing contemporary aggressive lipid-lowering management for dyslipidaemia: a sub-analysis of the HIJ-PROPER study （Poster notice，General） 2018/08/28
67.	The impact of additional mineralocorticoid receptor antagonist on guideline-recommended medical therapy in acute heart failure patients with ischemic heart disease （Poster notice，General） 2018/08/28
68.	Therapeutic validity and effectiveness of guideline-recommended medical therapy in acute heart failure patients on regular hemodialysis （Poster notice，General） 2018/08/28
69.	Underdiagnosis and non-treatment of heterozygous familial hypercholesterolemia in association with cardiovascular disease （Poster notice，General） 2018/08/28
70.	Comparison of risk factors for cardiovascular outcomes between patients with and without diabetes: results from the HIJ-PROPER Study （Poster notice，General） 2018/08/26
71.	Guideline-recommended medication including mineralocorticoid-receptor antagonists is associated with better long-term outcomes in octogenarian patients with acute heart failure （Speech，General） 2018/08/25
72.	Insight into Polygenetic Abnormalities in Japanese Heterozygous Familial Hypercholesterolemia （Poster notice，General） 2018/06/10
73.	Proprotein Convertase Subtilisin/kexin Type 9 (PCSK-9) inhibitors Improve Lipid Profile and Vascular Atherosclerotic Plaque in Familial Hypercholesterolemia （Poster notice，General） 2018/06/09
74.	The impact of Brain atrophy in the young patients with severe heart failure （Speech，General） 2018/05/26
75.	Optimized settings for adaptive servo ventilation in patients with severe heart failure based on the echocardiogram （Poster notice，General） 2018/05/19
76.	The impact of Brain atrophy in the young patients with severe heart failure （Speech，General） 2018/05/19
77.	Aortic Valve Calcification and Subclinical Coronary Atherosclerosis Using Computed Tomography in Japanese Heterozygous Familial Hypercholesterolemia Patients with Gene Mutation （Poster notice，General） 2018/03/25
78.	Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitors Improve Lipid Profile and Vascular Atherosclerotic Plaque Formation in High-risk Familial Hypercholesterolemia. （Poster notice，General） 2018/03/25
79.	Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9) Inhibitors Improve Lipid Profile and Vascular Atherosclerotic Plaque Formation in High-risk Familial Hypercholesterolemia. （Poster notice，General） 2018/03/25
80.	Heterozygous Familial Hypercholesterolemia: Insight into Polygenetic Abnormalities in Japanese Patients （Speech，General） 2018/03/24
81.	Assessment of Cardiovascular Atherosclerosis of Heterozygous Familial Hypercholesterolemia (hFH) Using 320-detector Row Coronary CT （Poster notice，General） 2018/03/23
82.	Association between Low-Density Lipoprotein-Cholesterol/High-Density Lipoprotein-Cholesterol Ratio and Clinical Outcomes in Patients with Acute Coronary Syndrome and Dyslipidemia: Subanalysis of the HIJ-PROPER （Speech，General） 2018/03/23
83.	Fundamental Differences in Conventional Risk Factors for Secondary Prevention in Patients with Acute Coronary Syndrome: A Post-hoc Analysis of HIJ-PROPER （Speech，General） 2018/03/23
84.	Quantitative Analysis of a Calcified Amorphous Tumor of the Heart Using Multi-detector Computed Tomography （Poster notice，General） 2018/03/23
85.	The Strict Management of Low-Density Lipoprotein Cholesterol in Heterozygous Familial Hypercholesterolemia for the Secondary Prevention of Cardiovascular Disease （Poster notice，General） 2018/03/23
86.	Underdiagnosis and Non-treatment of Heterozygous Familial Hypercholesterolemia in Association with Cardiovascular Disease （Speech，General） 2018/03/23
87.	Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK-9)Inhibitors Improve Lipid Profile and Vascular Atherosclerotic Plaque Formation in High-Risk Familial Hypercholesterolemia （Poster notice，General） 2018/03/11
88.	The Impact of Brain Atrophy in the Patient with Young Patients with Severe Heart Failure （Poster notice，General） 2018/03/11
89.	Association Between the Low-Density Lipopotein Cholesterol/High-Density Lipoprotein-Cholesterol Ratio and Clinical Outcomes in Patients With Acute Coronary Syndrome and Dyslipidemia: A Subanalysis of the HIJ-PROPER Study （Poster notice，General） 2018/03/10
90.	Impact of High-sensitivity C-reactive Protein Level on Clinical Outcomes of Acute Coronary Syndrome Patients with Dyslipidemia Undergoing Contemporary Lipid-lowering Therapy （Poster notice，General） 2018/03/10
91.	Polygenetic Abnormalities in Japanese Patients With Heterozygous Familial Hypercholesterolemia （Poster notice，General） 2018/03/10
92.	The Impact of Decreased High-Density LipoproteinCholesterol Level After Lipid-lowering Therapy on the Clinical Outcomes in Patients With Acute Coronary Syndrome and Dyslipidemia: A Subanalysis of the HIJ-PROPER Study （Poster notice，General） 2018/03/10
93.	Insight into Polygenetic Abnormalities in Japanese Heterozygous Familial Hypercholesterolemia （Poster notice，General） 2018/01/06
94.	Impact of Type 2 Diabetes on Optimal Target LDL-C Level for Secondary Prevention of Cardiovascular Disease in Patients With Acute Coronary Syndrome: A Subanalysis of HIJ-PROPER （Poster notice，General） 2017/11/14
95.	Underdiagnosis and Undertreatment of Heterozygous Familial Hypercholesterolemia in Association With Cardiovascular Disease （Poster notice，General） 2017/11/14
96.	Diastolic Blood Pressure is the Predictors of Left Ventricular Myocardial Relaxation in Healthy Postmenopausal Women （Poster notice，General） 2017/11/13
97.	Aortic valve calcification and coronary plaque morphology in Japanese heterozygous familial hypercholestestreolemia patients with gene mutation （Poster notice，General） 2017/11/11
98.	The impact of Brain atrophy in the patient with young patients with severe heart failure （Speech，General） 2017/10/12
99.	Gender Difference of Atherosclerotic Development in Heterozygous Familial Hypercholesterelemia （Poster notice，General） 2017/09/16
100.	Sex-related differences in coronary risk factors of major adverse cardiovascular events in acute coronary syndrome with contemporary dyslipidaemia management: a sub-analysis of data from the HIJ-PROPER （Poster notice，General） 2017/08/29
101.	Under-diagnosis and Under-treatment of Heterozygous Familial Hypercholesterelaemia in Patients with Cardiovascular Diseases （Poster notice，General） 2017/08/29
102.	The impact of serum sitosterol level on clinical outcomes in acute coronary syndrome patients with dyslipidemia: a subanalysis of HIJ PROPER （Poster notice，General） 2017/08/27
103.	The impact of high-sensitive C-reactive protein value and renal function on clinical outcomes in patients with acute coronary syndrome under aggressive lipid lowering therapy: a sub-analysis of HIJ PR （Poster notice，General） 2017/08/26
104.	Polygenetic Abnormalities in Japanese Patients with Heterozygous Familial Hypercholesterolemia （Poster notice，General） 2017/07/07
105.	Assessment of cardiovascular atherosclerosis of heterozygous familial hypercholesterolemia (hFH) using 320-slice coronary CT （Speech，General） 2017/07/06
106.	Underdiagnosis and Under Treatment of Heterozygous Familial Hypercholesterelemia in Cardiovascular Diseases （Poster notice，General） 2017/03/19
107.	Adverse Effect of Underuse of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Therapy in Elderly Patients Hospitalized with Heart Failure （Poster notice，General） 2017/03/18
108.	Comparison of Decongestion Effect between Single and Divided-dose Administration of Tolvaptan in Acute Heart Failure （Poster notice，General） 2017/03/18
109.	Persistent High Blood Urea Nitrogen Level is Associated with Increased Cardiovascular Mortality in Acute Heart Failure Patients （Poster notice，General） 2017/03/18
110.	The prevalence of polygenetic abnormality in heterozygous familial hypercholesterolemia （Poster notice，General） 2017/03/18
111.	Cancer Antigen-125 Plasma Level as a Biomarker of New-Onset Atrial Fibrillation in Postmenopausal Women （Poster notice，General） 2017/03/17
112.	Endothelial Function and Sleep Quality in the Patients of Obstructive Sleep Apnea (OSA) （Poster notice，General） 2017/03/17
113.	Prognostic Factors in Japanese Elderly Heart Failure with Preserved Ejection Fraction: From the HIJ-HF II Cohort Study （Speech，General） 2017/03/17
114.	Rapid Resolution of Tendon Xanthomas in Elder Heterozygous Familial Hyperchorestelemia Treated With Evolocumab （Poster notice，General） 2017/03/17
115.	Serum Copeptin is a New Biomarker of Continuous-Positive-Airway-Pressure Treatment in Patients with Severe Obstructive Sleep Apnea （Poster notice，General） 2017/03/17
116.	Plasma Levels of Cancer Antigen-125 as a Biomarker of Paroxysmal or Persistent Atrial Fibrillation in Postmenopausal Women （Poster notice，General） 2016/11/13
117.	Waist circumference and systolic blood pressure: predictors of left ventricular hypertrophy in healthy subjects （Poster notice，General） 2016/08/30
118.	Comparison of equations that use cystatin C and creatinine levels for estimating glomerular filtration ratio in elderly Japanese patients with chronic heart failure （Poster notice，General） 2016/08/29
119.	Current Smoking Increases Prevalence of Asymptomatic Obstructive Sleep Apnea Syndrome （Poster notice，General） 2016/03/20
120.	Waist Circumference And Systolic Blood Pressure Are Predictors Of Left Ventricular Hypertrophy In Healthy Individuals. （Poster notice，General） 2015/11/08
121.	Low oxygen concentration is an associated risk of contrast induced nephropathy in patients with impaired renal function after cardiovascular angiography （Speech，General） 2015/09/02
122.	Gender differences in predictors of left ventricular myocardial relaxation in non-obese, healthy individuals （Poster notice，General） 2015/08/31
123.	Nocturnal hypertension in patients with Lewy Body disease （Poster notice，General） 2015/06/15
124.	Theophylline improved symptomatic postprandial hypotension in elderly （Poster notice，General） 2015/06/14
125.	Diastolic blood pressure is the predictors of left ventricular myocardial relaxation in healthy postmenopausal women （Poster notice，General） 2015/06/13
126.	Effects and mechanisms of action of theophylline for postprandial hypotension （Poster notice，General） 2015/06/13
127.	SYSTOLIC BLOOD PRESSURE AND WAIST CIRCUMFERENCE ARE THE PREDICTORS OF LEFT VENTRICULAR HYPERTROPHY IN HEALTHY ADULTS （Poster notice，General） 2015/06/13
128.	COMPARING GFR ESTIMATING EQUATIONS USING CYSTATIN C AND CREATININE IN ELDERLY JAPANESE WITH CHRONIC HEART FAILURE （Poster notice，General） 2015/04/30
129.	Marked Improvement of Elderly Symptomatic Postprandial Hypotension by Xanthine Derivatives and Preparations （Poster notice，Panelist at Symposium/Workshop (Appointed)） 2015/03/14
130.	Prevalence and characteristics of myocardial crypts in Japanese patients referred for cardiovascular magnetic resonance （Poster notice，General） 2015/02/07
131.	INCIDENCE OF ED IN MEN WITH SLEEP APNEA SYNDROME （Speech，General） 2013/06/01
132.	C-reactive Protein Level Predicts the Mortality of Acute Myocardial Infarction in Reperfusion Era-From the HIJAMI Registry(Infection/Inflammation/Immunity （Poster notice，General） 2005/03/19
Display 5 items
Display all(132)

■ Research grants & projects

1.	2015/04～2017/03	Oxygen Preconditioning Prevents Contrast -Induced Nephropathy after contrast Comp uted Tomography (OptionCINcontrastCT) (Key Word : )
2.	2013/11～2014/03	Oxygen Preconditioning Prevents Contrast-Induced Nephropathy after contrast Computed Tomography (OptionCINcontrastCT) (Key Word : )

■ Committee memberships

1.		Japan Atherosclerosis Society Councilor
2.		Japanese College of Cardiology Fellow of the Japanese College of Cardiology (FJCC)
3.	2026/09/12～2026/09/12	The 74th Annual Scientific Session of the Japanese College of Cardiology (Nagasaki) Chairperson, Oral Session 15 "Heart Failure / Cardiomyopathy 3" (O-15-1 to O-15-6)
4.	2021/04/01～	The Japanese Vascular Biology and Medicine Organization (JVBMO) Councilor
5.	2018/07/01～	American College of Physicians Fellows of the American College of Physicians (FACP)
6.	2016/03/21～	American Heart Association International Fellow of the American Heart Association (FAHA) Council of Clinical Cardiology
7.	2014/12/25～	Asian Pacific Society of Cardiology Fellow of the Asian Pacific Society of Cardiology (FAPSC)
8.	2014/04/01～	Japan section for International Society of Cardiovascular Pharmacotherapy
Display 5 items
Display all(8)

■ Awards & honors

1.	2018/05	International Atherosclerosis Society Travel Grant
2.	2014/11	American Heart Association Early Career poster winner for Scientific Sessions 2014 (Prevention of Contrast-Induced Nephropathy by Oxygen Preconditioning in Patients With Impaired Renal Function)

■ Patents

2013/04/25

CONTRAST AGENT, CONTRAST AGENT KIT, AND METHOD FOR ADMINISTERING CONTRAST AGENT